Dual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares Higher
15 Abril 2024 - 10:07AM
AllPennyStocks.com
Shares of this firm hit a 12-month high last week and are seeing
action this morning after they announced the completion of the sale
of its interest in an animal health unit for USD$8,000,000.
Kane...
To read the full story on AllPennyStocks.com, click
here.
Kane Biotech (TSXV:KNE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Kane Biotech (TSXV:KNE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
